Internal Medicine, Hematology & Oncology · Tulsa, OK
NPI
1922494202
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
11212 E 48th St
Tulsa, OK, 74146
Phone (918) 556-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
1,692 services
Medicare patients, 2024
326
Average age 73
Drug cost, 2024
$1.4M
1,546 prescriptions
Company payments, 2025
$2,130
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephanie S Harry was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 667 times for 239 patients. In total Stephanie S Harry billed 1,692 services in 11 codes, and Medicare paid $77K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 667 | 239 | $11.54 | $7,695 |
| 99214 Office E&M - Established | Office | 578 | 198 | $66.46 | $38K |
| 99232 Hospital E&M - Subsequent | Facility | 183 | 57 | $57.44 | $11K |
| 99213 Office E&M - Established | Office | 94 | 71 | $44.23 | $4,158 |
| 99222 Hospital E&M - Initial | Facility | 78 | 67 | $94.45 | $7,367 |
| 99204 Office E&M - New | Office | 42 | 42 | $88.37 | $3,711 |
| 99205 Office E&M - New | Office | 23 | 23 | $131.00 | $3,013 |
| 99203 Office E&M - New | Office | 15 | 15 | $59.28 | $889 |
By year: 2022 $78K for 862 services; 2023 $80K for 1,026 services; 2024 $77K for 1,692 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephanie S Harry prescribed most often to Medicare patients was Anastrozole, with 182 prescriptions and refills. In total Stephanie S Harry wrote 1,546 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 182 | 359 | 43 | $4,533 |
| Warfarin Sodium Generic | 97 | 153 | Under 11 | $461 |
| Prochlorperazine Maleate Generic | 90 | 90 | 53 | $915 |
| Eliquis Apixaban | 75 | 109 | 17 | $61K |
| Ondansetron Odt Ondansetron | 56 | 56 | 39 | $732 |
| Gabapentin Generic | 50 | 52 | 11 | $339 |
| Oxycodone Hcl Generic | 45 | 45 | 16 | $806 |
| Acyclovir Generic | 43 | 47 | Under 11 | $631 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 39 | 53 | Under 11 | $470 |
| Prednisone Generic | 36 | 40 | 16 | $143 |
| Hydroxyurea Generic | 34 | 42 | Under 11 | $532 |
| Potassium Chloride Generic | 33 | 40 | Under 11 | $279 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 31 | 31 | 14 | $563 |
| Lorazepam Generic | 26 | 26 | 12 | $45.28 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 25 | 25 | Under 11 | $726 |
Brand drugs: 233 claims; generic drugs: 1,313 claims; opioid claims: 168.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephanie S Harry $2,130 ($2,130 in general payments such as food, travel and fees) from 31 companies. The largest payer was Novartis Pharmaceuticals Corporation with $273.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 16 | $273 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $185 |
| Celgene Corporation BMY | 15 | $176 |
| Daiichi Sankyo Inc. 4568.T | 11 | $175 |
| Genzyme Corporation SNY | 7 | $136 |
| Aveo Pharmaceuticals, Inc. | 6 | $116 |
| Abbvie Inc. ABBV | 5 | $99.24 |
| Janssen Biotech, Inc. JNJ | 5 | $96.8 |
| Lilly USA, LLC LLY | 4 | $63.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.